What is Hepatitis-B? How do we treat it?
- Hepatitis B Virus infection is a significant health problem worldwide, affecting more than 350 million people. This virus can cause chronic liver problems, liver cirrhosis, and hepatocellular carcinoma.
- HM Foundation Care Clinic’s HBV Treatment for acute and chronic Hepatitis-B Virus (HBV) primarily focuses on the viral entry inhibition of HBV virus (DNA Polymerase) combined with other multi-targets. This blocks re-infection and protects hepatocytes (also called healthy liver cells), opening new natural therapeutic options without side effects for HBV-infected individuals.
- The treatment is based on the herbal composite formula, ensuring effective action on multiple targets. Its anti-HBV, anti-Hepatocellular Carcinoma (HCC), and Hepatoprotective.
5 way actions to combat HBV with the HM Foundation's Treatment
- Successive Virologic Response (No viral relapse).
- Prevents viral induced Hepatocellular Carcinoma
- Normalize Liver enzymes (SGPT, SGOT)
- Reported HBV DNA PCR Not Detected
- Anti-HBs Restoration
Common FAQs regarding Hepatitis
Most frequent questions and answers
Hepatitis-B (also known as HBV) is an infection caused by the hepatitis B virus, also called HB virus, in which mainly the liver is involved. According to World Health Organisation, “Two billion people have been infected with the hepatitis B virus (one out of three people). Approximately 1.5 million people become newly infected each year. Almost 300 million people are chronically infected. Approximately 10% of infected individuals are diagnosed”
Hepatitis-B can transmitted sexually and also through blood in case of blood transfusion
Hepatitis-B test can be done via three mediums:- Blood Test, Liver Ultrasound and Liver Biopsy. A simple blood test can also determine if you’re immune to the condition. A special ultrasound called transient elastography can show the amount of liver damage. And finally, in Liver Biopsy, A small part of the liver is taken through a thin needle to check the Liver damage.
HM Foundation Care Clinic’s Anti Hepatitis Treatment consists of a herbal composite formula that simultaneously ensures effective action on multiple targets (anti-HBV, anti-Hepatocellular Carcinoma (HCC), and Hepatoprotective). This treatment has been extensively studied against Hepatitis-B Virus on the inhibition of HBsAg secretion PLC/PRF/5 cells and the inhibition of Hepato carcinoma in the HepG2 cell line. Clinically patients receiving Treatment have reported complete elimination of HBV up to the “Target not detected” in HBV DNA Quantitative. Further HBSAG test report “Negative” confirming complete cure of Hepatitis B.
HM Foundation’s treatment eliminates the HBV DNA from the body, which is why the patients, after undergoing HIMP – B treatment for HBV, were monitored and observed a 10-fold decrease in HBV DNA viral load within 4-6 months. The treatment will continue till the patient reports Target Not Detected for HBV DNA Quantitative.
After the patient reports Target Not Detected for the HBV DNA Quantitative test within 6-8 months, the treatment has to be continued to complete the course of treatment for 10-12 months till the patient reports Not Detected for HBV DNA Qualitative test.
HBsAg test records were Negative for the patient after the treatment with HIMP-B confirming complete cure.
AFTER WHICH TREATMENT IS COMPLETELY STOPPED
Read More about Hepatitis-B
Anti-HBs Restoration In Hepatitis B
Read More
Hepatitis Treatment by HM Foundation: One of its own kind
Read More
Hepatitis can be more dangerous than HIV
Read More
Case Study of Cured Patients
Lucas Onesmo from Tanzania
- The patient who has undergone our treatment recorded a negative result for HBsAg (Hepatitis – B)
- Apart from conducting tests for HBV serological markers, such as HBsAg, anti-HBs, and HBV DNA, to track the patient’s viral load inhibition progress, it is also essential to monitor the patient’s liver function using serum alanine transaminase (ALT) and aspartate transaminase (AST) tests. The patient has received treatment for two years (from November 2019 to November 2021), and all the tests mentioned above show normal results, indicating that the patient has an excellent hepatic function.
- Based on the information provided, Luka has fully recovered from his Hepatitis B infection after receiving treatment with HM Foundation’s Treatment. His HBV DNA PCR test returned negative, indicating that the virus has been successfully eradicated and is no longer replicating in his body.
Kiran Kotiyan from India
Based on the information provided, it appears that the individual was initially diagnosed with hepatitis B virus (HBV) in May 2018, with a positive result for HBsAg and a high viral load of 749820 cp/ml. They began treatment with HM Foundation’s Treatment in May 2018, and by December 2018, their viral load had decreased significantly to 23100 cp/ml, but they were still positive for HBsAg.
However, by June 2019, the individual had achieved a target not detected result for HBV DNA, indicating that the viral load had dropped to undetectable levels. Additionally, their HBsAg result was negative, which suggests that the individual may have cleared the infection or achieved a state of inactive carrier status.
Our Blog
Anti-HBs Restoration In Hepatitis B
Read More
Hepatitis Treatment by HM Foundation: One of its own kind
Read More
Hepatitis can be more dangerous than HIV
Read More
Our Blog
Anti-HBs Restoration In Hepatitis B
Read More
Hepatitis Treatment by HM Foundation: One of its own kind
Read More
Hepatitis can be more dangerous than HIV
Read More
